A serum biomarker may predict response to immunotherapy drugs that target immune checkpoints
Serum levels of ANGPT2, a protein related to angiogenesis (blood vessel formation), was found to predict response to and influence the outcomes of treatment with a class of immunotherapeutics called immune checkpoint inhibitors ...
Dec 22, 2016
0
0